/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI)..
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI)..
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI)..
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI)..
NEW YORK, Aug. 28, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. . Such investors are advised to contact Robert.